Suppressor of cytokine signaling 3 is a physiological regulator of adipocyte insulin signaling

被引:183
作者
Shi, H
Tzameli, I
Bjorbæk, C
Flier, JS
机构
[1] Beth Israel Deaconess Med Ctr, Div Endocrinol, Boston, MA 02215 USA
[2] Harvard Univ, Sch Med, Boston, MA 02215 USA
关键词
D O I
10.1074/jbc.M403886200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Many proinflammatory cytokines and hormones have been demonstrated to be involved in insulin resistance. However, the molecular mechanisms whereby these cytokines and hormones inhibit insulin signaling are not completely understood. We observed that several cytokines and hormones that induce insulin resistance also stimulate SOCS3 expression in 3T3-L1 adipocytes and that SOCS3 mRNA is increased in adipose tissue of obese/diabetic mice. We then hypothesized that SOCS3 may mediate cytokine- and hormone-induced insulin resistance. By using SOCS3-deficient adipocytes differentiated from mouse embryonic fibroblasts, we found that SOCS3 deficiency increases insulin-stimulated IRS1 and IRS2 phosphorylation, IRS-associated phosphatidylinositol 3-kinase activity, and insulin-stimulated glucose uptake. Moreover, lack of SOCS3 substantially limits the inhibitory effects of tumor necrosis factor-alpha to suppress IRS1 and IRS2 tyrosine phosphorylation, phosphatidylinositol 3-kinase activity, and glucose uptake in adipocytes. The ameliorated insulin signaling in SOCS3-deficient adipocytes is mainly due to the suppression of tumor necrosis factor-alpha-induced IRS1 and IRS2 protein degradation. Therefore, our data suggest that endogenous SOCS3 expression is a key determinant of basal insulin signaling and is an important molecular mediator of cytokine- induced insulin resistance in adipocytes. We conclude that SOCS3 plays an important role in mediating insulin resistance and may be an excellent target for therapeutic intervention in insulin resistance and type II diabetes.
引用
收藏
页码:34733 / 34740
页数:8
相关论文
共 40 条
[1]   Identification of SOCS-3 as a potential mediator of central leptin resistance [J].
Bjorbaek, C ;
Elmquist, JK ;
Frantz, JD ;
Shoelson, SE ;
Flier, JS .
MOLECULAR CELL, 1998, 1 (04) :619-625
[2]   The role of SOCS-3 in leptin signaling and leptin resistance [J].
Bjorbæk, C ;
El-Haschimi, K ;
Frantz, JD ;
Flier, JS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (42) :30059-30065
[3]   Adipocyte insensitivity to insulin in growth hormone-transgenic mice [J].
Chen, XL ;
Lee, K ;
Hartzell, DL ;
Dean, RG ;
Hausman, GJ ;
McGraw, RA ;
Della-Fera, MA ;
Baile, CA .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 283 (04) :933-937
[4]   SOCS-3 is an insulin-induced negative regulator of insulin signaling [J].
Emanuelli, B ;
Peraldi, P ;
Filloux, C ;
Sawka-Verhelle, D ;
Hilton, D ;
Van Obberghen, E .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (21) :15985-15991
[5]   SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-α in the adipose tissue of obese mice [J].
Emanuelli, B ;
Peraldi, P ;
Filloux, C ;
Chavey, C ;
Freidinger, K ;
Hilton, DJ ;
Hotamisligil, GS ;
Van Obberghen, E .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (51) :47944-47949
[6]   A new protein containing an SH2 domain that inhibits JAK kinases [J].
Endo, TA ;
Masuhara, M ;
Yokouchi, M ;
Suzuki, R ;
Sakamoto, H ;
Mitsui, K ;
Matsumoto, A ;
Tanimura, S ;
Ohtsubo, M ;
Misawa, H ;
Miyazaki, T ;
Leonor, N ;
Taniguchi, T ;
Fujita, T ;
Kanakura, Y ;
Komiya, S ;
Yoshimura, A .
NATURE, 1997, 387 (6636) :921-924
[7]   Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels - A potential role for serine phosphorylation in insulin/angiotensin II crosstalk [J].
Folli, F ;
Kahn, CR ;
Hansen, H ;
Bouchie, JL ;
Feener, EP .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (09) :2158-2169
[8]   Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: Depot difference and regulation by glucocorticoid [J].
Fried, SK ;
Bunkin, DA ;
Greenberg, AS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (03) :847-850
[9]   A central role for JNK in obesity and insulin resistance [J].
Hirosumi, J ;
Tuncman, G ;
Chang, LF ;
Görgün, CZ ;
Uysal, KT ;
Maeda, K ;
Karin, M ;
Hotamisligil, GS .
NATURE, 2002, 420 (6913) :333-336
[10]   Inflammatory pathways and insulin action [J].
Hotamisligil, GS .
INTERNATIONAL JOURNAL OF OBESITY, 2003, 27 (Suppl 3) :S53-S55